EUVIMEDEUVIMED entdecken
Crossref

Outcomes of surgical resection and vagus nerve stimulation in patients with medically refractory epilepsy and glutamic acid decarboxylase 65 antibody positivity

Hannah H Zhao-Fleming, Yong Guo, Jeffrey W Britton, Divyanshu Dubey iD, Kelsey M Smith iD

Epilepsia · 2024-10 · 65 (10)

DOI: 10.1111/epi.18086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 07.08.2024. Verfasst von Hannah H Zhao-Fleming und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Drug Resistant Epilepsy, Glutamate Decarboxylase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy associated with high‐titer glutamic acid decarboxylase 65 (GAD65) IgG is often refractory to immunotherapies and antiseizure medication. This study sought to determine the efficacy of vagus nerve stimulation (VNS) and surgical resection in patients with drug‐resistant epilepsy associated with GAD65‐IgG. We retrospectively identified 15 patients with drug‐resistant epilepsy and high serum GAD65 antibody titers (>20 nmol·L −1 ) who underwent VNS implantation ( n = 6), surgical resection ( n = 7), or both ( n = 2). A responder to VNS was defined as someone with a ≥50% reduction in seizure frequency, and a favorable surgical outcome was defined as Engel I–II. Of the eight patients who underwent VNS implantation, three (37.5%) were initially responders, but this was not sustained in two. Of the nine patients who underwent surgical resection, three (33.3%) had a favorable outcome; however, only one patient was seizure‐free at last follow‐up. Pathology was available in six patients, and only one had evidence of inflammation; this patient had seizure onset 1 year prior to surgery. Favorable seizure outcome correlated with older age at time of resective surgery, with a trend favoring later age of seizure onset. Taken together, surgical resection and VNS implantation may have limited efficacy in this patient population but can be considered in carefully selected cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vagus Nerve StimulationDrug Resistant EpilepsyGlutamate DecarboxylaseHumansMaleFemaleAdultTreatment OutcomeRetrospective StudiesAdolescentYoung AdultMiddle AgedAutoantibodiesChild

Stichwörter der Autor:innen

GAD65‐IgG autoimmunityautoimmune associated seizure disorderepilepsy surgeryvagus nerve stimulator

Substanzen

Glutamate Decarboxylaseglutamate decarboxylase 2Autoantibodies

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Divyanshu Dubey, Kelsey M Smith

Zitieren

APA

Zhao-Fleming, H. H., Guo, Y., Britton, J. W., Dubey, D., & Smith, K. M. (2024). Outcomes of surgical resection and vagus nerve stimulation in patients with medically refractory epilepsy and glutamic acid decarboxylase 65 antibody positivity. Epilepsia, 65(10). https://doi.org/10.1111/epi.18086

Vancouver

Zhao-Fleming HH, Guo Y, Britton JW, Dubey D, Smith KM. Outcomes of surgical resection and vagus nerve stimulation in patients with medically refractory epilepsy and glutamic acid decarboxylase 65 antibody positivity. Epilepsia. 2024;65(10). doi:10.1111/epi.18086

BibTeX
@article{ZhaoFleming2024,
  author = {Zhao-Fleming, Hannah H and Guo, Yong and Britton, Jeffrey W and Dubey, Divyanshu and Smith, Kelsey M},
  title = {Outcomes of surgical resection and vagus nerve stimulation in patients with medically refractory epilepsy and glutamic acid decarboxylase 65 antibody positivity},
  journal = {Epilepsia},
  year = {2024},
  volume = {65},
  number = {10},
  doi = {10.1111/epi.18086}
}
Kostenlos starten →